We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

111 hedge funds and large institutions have $468M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more capital invested

Capital invested by funds: $252M → $468M (+$215M)

80% more call options, than puts

Call options by funds: $17.6M | Put options by funds: $9.77M

62% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 29

19% more funds holding

Funds holding: 93111 (+18)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
111
Holders Change
+18
Holders Change %
+19.35%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
47
Increased
26
Reduced
26
Closed
29
Calls
$17.6M
Puts
$9.77M
Net Calls
+$7.86M
Net Calls Change
+$7.28M

RPTP Hedge Fund Activity: Q3 2016 in Review

111 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q3 2016, worth a combined $468M — up 85% from $252M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new RPTP positions and 29 closed out — a net gain of 18 holders — while 26 added to existing stakes and 26 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $28.9M. The largest seller was Broadfin Capital, cutting an estimated $41.1M.

  • 111 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q3 2016, up from 93 in Q2 2016.
  • Funds reported $468M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q3 2016, up 85% quarter-over-quarter.
  • 47 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q3 2016 and 29 closed out, a net change of +18 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q3 2016 was AQR Arbitrage, an estimated $28.9M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q3 2016 was Broadfin Capital, an estimated $41.1M sold.

Based on aggregated 13F filings for Q3 2016.